Ad26.Mos4.HIV vaccine (adenovirus serotype 26 mosaic4 HIV vaccine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ad26.Mos4.HIV vaccine (adenovirus serotype 26 mosaic4 HIV vaccine), covering 2024-07-31 to 2024-07-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have Sex With Cis-gender Men and/or Transgender Individuals [Phase 3]